SLI
2.106,36
PKT
-4,25
PKT
-0,20
%
Werbung
Analysen zu SLI-Werten
| Datum | Rating | Analyst | |
|---|---|---|---|
| 27.03.15 | Swiss Re Neutral | Goldman Sachs Group Inc. | |
| 27.03.15 | Zurich Insurance Neutral | Goldman Sachs Group Inc. | |
| 26.03.15 | Givaudan overweight | JP Morgan Chase & Co. | |
| 26.03.15 | Nestlé overweight | JP Morgan Chase & Co. | |
| 26.03.15 | Zurich Insurance Hold | Deutsche Bank AG | |
| 25.03.15 | Swiss Re buy | Deutsche Bank AG | |
| 25.03.15 | Holcim buy | Deutsche Bank AG | |
| 25.03.15 | Holcim buy | Deutsche Bank AG | |
| 25.03.15 | Swiss Re Hold | Société Générale Group S.A. (SG) | |
| 24.03.15 | ABB (Asea Brown Boveri) Sell | Deutsche Bank AG | |
| 24.03.15 | Holcim buy | Deutsche Bank AG | |
| 24.03.15 | Holcim buy | Deutsche Bank AG | |
| 23.03.15 | Nestlé Neutral | UBS AG | |
| 20.03.15 | Holcim buy | S&P Capital IQ | |
| 20.03.15 | Holcim Sell | S&P Capital IQ | |
| 19.03.15 | UBS Equal-Weight | Morgan Stanley | |
| 19.03.15 | Nestlé overweight | Morgan Stanley | |
| 19.03.15 | Zurich Insurance Outperform | Credit Suisse Group | |
| 18.03.15 | ABB (Asea Brown Boveri) Sell | Deutsche Bank AG | |
| 18.03.15 | Holcim buy | Deutsche Bank AG | |
| 18.03.15 | Nestlé Underperform | BNP PARIBAS | |
| 17.03.15 | UBS Underperform | Macquarie Research | |
| 17.03.15 | UBS Halten | Independent Research GmbH | |
| 17.03.15 | ABB (Asea Brown Boveri) Underweight | HSBC | |
| 17.03.15 | Holcim Hold | Joh. Berenberg, Gossler & Co. KG (Berenberg Bank) | |
| 17.03.15 | Holcim Hold | Joh. Berenberg, Gossler & Co. KG (Berenberg Bank) | |
| 16.03.15 | Holcim Sell | S&P Capital IQ | |
| 16.03.15 | Nestlé Sell | Goldman Sachs Group Inc. | |
| 13.03.15 | Holcim Neutral | UBS AG | |
| 13.03.15 | UBS Hold | Commerzbank AG | |
| 12.03.15 | ABB (Asea Brown Boveri) Neutral | Nomura | |
| 11.03.15 | UBS neutral | Morgan Stanley | |
| 11.03.15 | UBS buy | Goldman Sachs Group Inc. | |
| 11.03.15 | UBS overweight | JP Morgan Chase & Co. | |
| 11.03.15 | UBS Neutral | UBS AG | |
| 09.03.15 | Nestlé Reduce | Nomura | |
| 04.03.15 | Roche Conviction Buy List | Goldman Sachs Group Inc. | |
| 04.03.15 | Roche Outperform | BNP PARIBAS | |
| 04.03.15 | Novartis Outperform | BNP PARIBAS | |
| 03.03.15 | Roche Conviction Buy | Goldman Sachs Group Inc. |